Tucson, AZ, United States of America

Daniel D Von Hoff

This inventor holds 1 USPTO granted patent. Top assignee: Pharma Mar, S.a.. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Daniel D Von Hoff. Retrieved from https://idiyas.com/inventor/daniel-d-von-hoff-jkdk66iy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Daniel D Von Hoff

Introduction

Daniel D Von Hoff is a prominent inventor based in Tucson, AZ (US). He is known for his significant contributions to cancer treatment through his innovative research and development. His work has led to advancements in medical therapies that aim to improve patient outcomes.

Latest Patents

Daniel D Von Hoff holds a patent for "Compositions and uses of ET743 for treating cancer." This patent focuses on the use of ET743 in the preparation of a medicament designed for the treatment of cancer in the human body. His innovative approach has the potential to enhance therapeutic options for patients battling this disease.

Career Highlights

Throughout his career, Daniel has made substantial contributions to the field of oncology. His work at Pharma Mar, S.A. has been instrumental in developing new cancer treatments. His dedication to research and innovation has positioned him as a leader in the medical community.

Collaborations

Daniel has collaborated with notable colleagues, including Cecilia Guzman and Luis Lopez Lazaro. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in cancer research.

Conclusion

Daniel D Von Hoff's innovative work in cancer treatment exemplifies the impact of dedicated research and collaboration in the medical field. His contributions continue to inspire advancements that may lead to better treatment options for patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…